CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-02-16 | Polymeropoulos Mihael Hristos President and CEO | Exercise or conversion | +18,750 | 427,500 | ||
| 2012-02-16 | Polymeropoulos Mihael Hristos President and CEO | Exercise or conversion | +12,500 | 440,000 | ||
| 2012-02-16 | Polymeropoulos Mihael Hristos President and CEO | Sale | −11,350 | $4.69 | $53K | 428,650 |
| 2012-02-16 | Polymeropoulos Mihael Hristos President and CEO | Exercise or conversion · Restricted Stock Unit | −18,750 | 37,500 | ||
| 2012-02-16 | Polymeropoulos Mihael Hristos President and CEO | Exercise or conversion · Restricted Stock Unit | −12,500 | 37,500 | ||
| 2012-02-16 | Kelly James Patrick SVP, CFO, Sec & Treasurer | Exercise or conversion | +12,500 | 17,500 | ||
| 2012-02-16 | Kelly James Patrick SVP, CFO, Sec & Treasurer | Sale | −4,920 | $4.67 | $23K | 12,580 |
| 2012-02-16 | Kelly James Patrick SVP, CFO, Sec & Treasurer | Exercise or conversion · Restricted Stock Unit | −12,500 | 37,500 | ||
| 2012-02-16 | Feeney John Joseph SVP & Chief Medical Officer | Exercise or conversion | +7,500 | 15,000 | ||
| 2012-02-16 | Feeney John Joseph SVP & Chief Medical Officer | Exercise or conversion | +4,687 | 19,687 | ||
| 2012-02-16 | Feeney John Joseph SVP & Chief Medical Officer | Sale | −4,760 | $4.65 | $22K | 14,927 |
| 2012-02-16 | Feeney John Joseph SVP & Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −7,500 | 15,000 | ||
| 2012-02-16 | Feeney John Joseph SVP & Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −4,687 | 14,063 | ||
| 2011-12-06 | Feeney John Joseph SVP & Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +56,250 | 56,250 | ||
| 2011-12-06 | Feeney John Joseph SVP & Chief Medical Officer | Grant or award · Restricted Stock Units | +18,750 | 18,750 | ||
| 2011-08-23 | Polymeropoulos Mihael Hristos President and CEO | Purchase | +7,920 | $5.35 | $42K | 408,750 |
| 2011-08-22 | Polymeropoulos Mihael Hristos President and CEO | Purchase | +2,080 | $5.34 | $11K | 400,830 |
Page 36 of 36 · 717 trades